This morning, laboratory instrumentation company Pressure BioSciences, Inc. (PBIO-OTC) announced that it had received the first purchase order for one of its newest products, the Barozyme™ HT48 High-throughput System, and had the potential for a second order for the same product. The possible second purchase could come from an existing European customer that has requested a quote.
 
About the Barozyme™ HT48

Pressure BioSciences, Inc. (PBIO-OTC) has reported its financial results for the third quarter 2014 and year-to-date period ended September 30th. Highlights of these results are an increase in products and services revenue of 14% for the third quarter, while operating loss continues to narrow. Year to date, the company reported products and services revenue up 45% and sales of consumables up 48%, which almost entirely offset the loss in grant revenue.

Pressure BioSciences, Inc. (PBIO-OTC) reported this morning that it has received an important third-party validation of the protein analysis possibilities enabled by its proprietary pressure cycling technology (PCT). Earlier this month, at the 13^th Human Proteome Organization World Congress in Madrid, Spain, renowned protein scientist Professor Ruedi Aebersold from ETH Zurich and the University of Zurich combined PCT with AB SCIEX’s SWATH mass spectrometry method, and was able to analyze thousands of proteins by mass spectrometry on small, needle biopsy samples. In presenting his process and findings, Dr. Aebersold noted that prior to the combination of the mass spectrometry method with Pressure BioSciences’ PCT platform, it had been nearly impossible to accomplish the quantification of thousands of proteins in needle biopsy samples.

Laboratory instrumentation company Pressure BioSciences, Inc. (PBIO-OTC) announced this morning that it had entered into an exclusive, three-year distribution agreement with a Chinese distributor of analytical instruments and other equipment to China's biotech, pharma, agricultural, environmental, food safety, and commercial laboratory markets. Pressure BioSciences reports that the company, Powertech Technology Company Ltd., is a recognized distributor to the Chinese market, with a network of 18 distribution offices, a maintenance center, an applications laboratory, and multiple sub-dealers. The press release further stated that Powertech's current business partners aside from Pressure BioSciences include Dupont, GE Healthcare, Sartorius, Zeiss, and Agilent.

This morning we published a 16-page Quarterly Update on laboratory instrumentation company, Pressure BioSciences, Inc. (PBIO-OTC). 

Pressure BioSciences, Inc. (PBIO-OTC), a company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market, will hold a conference call to update investors on its business and financial results on Thursday, August 14, 2014. The call will cover the company's financial results for the second quarter 2014.

Today Pressure BioSciences, Inc. (PBIO-OTC) announced a relationship with IssuWorks, a company that strives to provide services and technology to improve capital formation, distribution, and aftermarket results for issuers, investors, and investment banks. Pressure BioSciences has retained IssuWorks and its management team to review the Company’s strategic and financing alternatives, including the possible spin-off of vertical market applications into new, stand-alone businesses.

This afternoon, we published an update on Pressure BioSciences, Inc. (PBIO-OTC), a company focused on the development and commercialization of proprietary laboratory instruments and consumable products. The update covers the company's most recently reported financial results for the first quarter 2014 and highlights from fiscal year 2013, as well as describes new product introductions, including a new pressure cycling technology (PCT) platform being introduced this week at the annual meeting of the American Society for Mass Spectrometry.

Pressure BioSciences, Inc. (PBIO-OTC), a company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market, announced financial results for the three-month period and fiscal year ended December 31, 2013, and provided a business update.

Upon news that over the past two months, Massachusetts-based Pressure BioSciences, Inc. (PBIO-OTC) has raised an excess of $2.2 million, and seeks to raise more in February 2014, it is time to look closer at the business of this small-cap company. A quick Google search will tell you that Pressure BioSciences makes laboratory instruments for the “sample preparation” market—a market that is integral to life science research in tens of thousands of laboratories worldwide. But what is sample preparation? Is there a market for Pressure BioSciences’ products?

What is Sample Preparation?